Project Grant R21DA062721
Award Date 8/1/25
Completion Date 7/31/27
Dollars Obligated $199K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
La Jolla, CA 92093, USA
Similar Awards
- This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), will provide $2,331,737 to the University of California, San Francisco (UCSF) to conduct research on the impact of methamphetamine use on immune dysfunction and HIV reservoir transcription among people with HIV receiving antiretroviral therapy. The research will utilize in vivo imaging and post-mortem studies to examine how methamphetamine use...
- This federal Project Grant, awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $804,728 to the Regents of the University of California at Riverside to investigate the role of the cysteinyl leukotriene-cysteinyl leukotriene receptor 1 (CYSLT-CYSLTR1) axis in promoting HIV-1 persistence and brain injury in individuals living with HIV who use methamphetamine. The 5-year project, starting June 1, 2025, aims to determine...
- The University of California, San Francisco (UCSF) was awarded a $206,180 Project Grant from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) to investigate the complex intersection of HIV, methamphetamine use, and immune dysfunction. The 5-year grant, awarded on Sep 1, 2025, will support a comprehensive, data-driven research approach to examine how methamphetamine exposure influences HIV reservoir transcription and host immune responses, with the...
- This federal Project Grant award, provided by the Department of Health and Human Services National Institutes of Health (CFDA 93.310 Trans-NIH Research Support program), will support a mixed-methods research study to understand the interplay of social and physical environments, loneliness, and cognition among older people living with HIV. The $123,579 award, with a performance period from June 15, 2025 to March 31, 2030, will be administered by Northeastern University. The research aims to...
- This Project Grant award of $1,573,958 from the National Institute on Drug Abuse (NIDA), part of the Drug Use and Addiction Research Programs (CFDA 93.279), is focused on identifying individuals who are viremic and/or have substance use disorder (SUD) to engage them for early intervention. The project will implement routine SUD screening using the NIDA Quick Screen and a social network intervention to find individuals who are viremic, have SUD, or both, and link them to harm reduction and HIV...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, awarded a $3,939,754 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the Northern California Institute for Research and Education, Inc. (NCIRE) for the "Stimulant and Polysubstance Use, Inflammation and Sex Effects on Myocardial Disease in HIV (SPISE)" research program. The goal of this 5-year project, beginning July 15, 2025, is to investigate the role of stimulant...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $608,652 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the Scripps Research Institute. The purpose of this 5-year award, with a start date of September 1, 2025, is to conduct data mining and functional validation of the Systematic Characterization of Retroviral Conditions for Health (SCORCH) datasets. The research aims to elucidate the key pathogenic...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $558,668 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the Massachusetts Institute of Technology (MIT) for the project "Integration and Validation of Single-Cell Neuronal and Immune Molecular Responses in SUD and HIV". The project aims to uncover the genetic and molecular mechanisms driving the interactions between HIV, neuropsychiatric, and...
- The University of California, San Diego (UCSD) was awarded a $2,223,769 Project Grant from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), with an award date of April 15, 2025 and an ultimate completion date of January 31, 2030. The grant will fund a comprehensive investigation to uncover the mechanistic intersection through which HIV and opioids heighten inflammation, with the goal of offering insights for targeted interventions...
- The National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded a $687,416 Project Grant to the J. David Gladstone Institutes in San Francisco, California. The grant is for a research project titled "Targeted Small Molecule Recruitment to Suppress the HIV Transcriptionally Active Reservoir" and runs from May 15, 2025 to March 31, 2030. The key objectives of this research project are to develop therapeutically effective...